![Nicoletta Loggia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicoletta Loggia
Hoofd Techniek/Wetenschap/O&O bij
ORCHARD THERAPEUTICS PLC
Vermogen: 17 770 $ op 31-05-2026
Profiel
Nicoletta Loggia is currently an Independent Director at Candel Therapeutics, Inc. since 2023 and Chief Technical Officer at Orchard Therapeutics Plc since 2021.
Formerly, Dr. Loggia was Head of Cell & Gene Therapies at Novartis AG from 2015 to 2021.
Education includes graduate and doctorate degrees from the University of Pavia.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2026 | 2.141 ( 0% ) | 17 770 $ | 31-05-2026 |
Actieve functies van Nicoletta Loggia
| Bedrijven | Functie | Begin |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Hoofd Techniek/Wetenschap/O&O | 09-09-2021 |
| CANDEL THERAPEUTICS, INC. | Directeur/Bestuurslid | 07-06-2023 |
Eerdere bekende functies van Nicoletta Loggia
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01-08-2021 |
Opleiding van Nicoletta Loggia
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
33
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Pavia
 University of Pavia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
